Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

AXGN – AxoGen, Inc.

AxoGen, Inc.
AXGN
$16.26
Name : AxoGen, Inc.
Sector : Healthcare
Industry: Medical Devices
Mark. Cap: $748,164,864.00
EPSttm : -0.1
finviz dynamic chart for AXGN
AxoGen, Inc.
$16.26
2.65%
$0.42

Float Short %

9.42

Margin Of Safety %

-35

Put/Call OI Ratio

0.16

EPS Next Q Diff

0.08

EPS Last/This Y

0.49

EPS This/Next Y

0.21

Price

16.26

Target Price

24.88

Analyst Recom

1.11

Performance Q

48.63

Relative Volume

0.87

Beta

1

Ticker: AXGN




21 items of 1

DateSymbolLastP/C OIP/C VolTotal OI
2025-07-25AXGN13.370.030.035293
2025-07-28AXGN130.030.015317
2025-07-29AXGN13.440.020.015780
2025-07-30AXGN13.20.020.006223
2025-07-31AXGN13.10.030.155833
2025-08-01AXGN12.660.030.046048
2025-08-04AXGN12.570.030.016088
2025-08-05AXGN13.720.030.026080
2025-08-06AXGN13.740.040.845604
2025-08-07AXGN14.050.040.815723
2025-08-08AXGN13.90.050.035757
2025-08-11AXGN14.020.050.105761
2025-08-12AXGN14.170.050.025793
2025-08-13AXGN14.750.060.035377
2025-08-14AXGN14.890.060.375511
2025-08-15AXGN14.960.060.075535
2025-08-18AXGN15.490.090.072832
2025-08-19AXGN15.380.090.903005
2025-08-20AXGN15.550.121.353011
2025-08-21AXGN15.850.140.373113
2025-08-22AXGN16.260.160.193356
DateSymbolLastP/C OIP/C VolTotal OI
21 items Current Page1 of 1




21 items of 1

DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
2025-07-25AXGN13.3720.0- 0.20
2025-07-28AXGN12.9120.0- 0.20
2025-07-29AXGN13.4320.0- 0.20
2025-07-30AXGN13.2020.0- 0.20
2025-07-31AXGN13.0920.0- 0.20
2025-08-01AXGN12.6720.0- 0.20
2025-08-04AXGN12.5520.0- 0.20
2025-08-05AXGN13.7220.0- 0.20
2025-08-06AXGN13.7720.0- 0.20
2025-08-07AXGN14.0720.0- 0.20
2025-08-08AXGN13.9020.0- 0.26
2025-08-11AXGN14.01-2.9- 0.26
2025-08-12AXGN14.17-2.9- 0.26
2025-08-13AXGN14.76-2.9- 0.26
2025-08-14AXGN14.89-2.9- 0.26
2025-08-15AXGN14.94-2.9- 0.26
2025-08-18AXGN15.50-2.9- 0.26
2025-08-19AXGN15.36-2.9- 0.26
2025-08-20AXGN15.54-2.9- 0.26
2025-08-21AXGN15.85-2.9- 0.26
2025-08-22AXGN16.26-2.9- 0.26
DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
21 items Current Page1 of 1




21 items of 1

DateTickerInsider TransactionsInstitutional TransactionsFloat Short
2025-07-25AXGN-3.689.677.16
2025-07-28AXGN-3.688.197.16
2025-07-29AXGN-3.688.197.16
2025-07-30AXGN-3.688.197.16
2025-07-31AXGN-3.688.197.16
2025-08-01AXGN-3.688.197.16
2025-08-04AXGN-3.688.237.16
2025-08-05AXGN-3.688.237.16
2025-08-06AXGN-3.688.237.16
2025-08-07AXGN-3.688.237.16
2025-08-08AXGN-3.658.237.09
2025-08-11AXGN-3.658.167.09
2025-08-12AXGN-3.658.169.42
2025-08-13AXGN-3.658.169.42
2025-08-14AXGN-3.658.169.42
2025-08-15AXGN-3.658.169.42
2025-08-18AXGN-3.656.139.42
2025-08-19AXGN-3.656.139.42
2025-08-20AXGN-3.656.139.42
2025-08-21AXGN-3.656.139.42
2025-08-22AXGN-3.656.139.42
DateTickerInsider TransactionsInstitutional TransactionsFloat Short
21 items Current Page1 of 1

Last Quarter Act. EPS

0.01

Avg. EPS Est. Current Quarter

0.07

Avg. EPS Est. Next Quarter

0.09

Insider Transactions

-3.65

Institutional Transactions

6.13

Beta

1

Average Sales Estimate Current Quarter

56

Average Sales Estimate Next Quarter

57

Fair Value

10.59

Quality Score

58

Growth Score

55

Sentiment Score

76

Actual DrawDown %

32.1

Max Drawdown 5-Year %

-84.6

Target Price

24.88

P/E

Forward P/E

34.11

PEG

P/S

3.68

P/B

6.63

P/Free Cash Flow

151.45

EPS

-0.11

Average EPS Est. Cur. Y​

0.26

EPS Next Y. (Est.)

0.47

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-2.29

Relative Volume

0.87

Return on Equity vs Sector %

-28.8

Return on Equity vs Industry %

-22.8

EPS 1 7Days Diff

0.1

EPS 1 30Days Diff

0.06

EBIT Estimation

AxoGen, Inc.
Sector: Healthcare
Industry: Medical Devices
Employees: 451
Axogen, Inc., together with its subsidiaries, develops and commercializes technologies for peripheral nerve regeneration and repair worldwide. The company's products include Avance Nerve Graft, a biologically active off-the-shelf processed human nerve allograft for bridging severed peripheral nerves without the comorbidities associated with a second surgical site; AxoGuard Nerve Connector, a porcine submucosa extracellular matrix (ECM) coaptation aid for tensionless repair of severed peripheral nerves; AxoGuard Nerve Protector, a porcine submucosa ECM product that is used to wrap and protect damaged peripheral nerves, as well as reinforces the nerve reconstruction while preventing soft tissue attachments; and Axoguard HA+ Nerve Protector, a processed porcine submucosa ECM base layer with a hyaluronate-alginate gel coating designed to provide short- and long-term protection for peripheral nerve injuries. Its products also comprise Axoguard Nerve Cap, a porcine submucosa ECM product that is used to protect a peripheral nerve end, as well as separates the nerve from the surrounding environment to reduce the development of symptomatic or painful neuroma. The company provides its products to hospitals, surgery centers, and military hospitals, plastic reconstructive surgeons, orthopedic and plastic hand surgeons, and various oral and maxillofacial surgeons. Axogen, Inc. is headquartered in Alachua, Florida.
stock quote shares AXGN – AxoGen, Inc. Stock Price stock today
news today AXGN – AxoGen, Inc. stock forecast ,stock prediction 2023 2024 2025
marketwatch AXGN – AxoGen, Inc. yahoo finance google finance
stock history AXGN – AxoGen, Inc. invest stock market
stock prices AXGN premarket after hours
ticker AXGN fair value insiders trading